Skip to main content
Top
Published in: Journal of Parasitic Diseases 3/2017

01-09-2017 | Original Article

Prevalence of Pneumocystis jirovecii among immunocompromised patients in hospitals of Tehran city, Iran

Authors: Mohammad Mohsen Homayouni, Hamed Behniafar, Amir Sayed Ali Mehbod, Mohammad-Javad Mohammad-Sadeghi, Bahman Maleki

Published in: Journal of Parasitic Diseases | Issue 3/2017

Login to get access

Abstract

Pneumocystis jirovecii is an opportunistic organism that can cause extreme complications such as Pneumocystis pneumonia in immunocompromised individuals. There is no comprehensive study was conducted Iran to determine the prevalence of this infection in susceptible individuals. In the present study, 160 sera samples were collected from immunocompromised patients, including acquired immunodeficiency syndrome (AIDS) patients, diabetic patients, Hodgkin lymphoma patients and non-Hodgkin lymphoma patients. The specimens were collected from Imam Khomeini and army’s 501 hospitals. The specimens were examined using indirect fluorescent antibody test. The results of the study showed that 39.30% specimens were found positive, with different rates in different groups, including 20, 22.50, 37.50, and 77.50% of diabetic patients, non-Hodgkin patients, Hodgkin lymphoma patients, and AIDS patients, respectively. This occurrence is relatively high and can be a potential life-threatening hazard to infected patients in studied groups, on the other hand the organism can be transmitted from infected people to other susceptible individuals.
Literature
go back to reference Alvarez-Martínez MJ, Miró JM, Valls ME, Moreno A, Rivas PV, Solé M, Domingo NP, Muñoz C, Rivera E (2006) Sensitivity and specificity of nested and real-time PCR for the detection of Pneumocystis jiroveci in clinical specimens. Diagn Microbiol Infect Dis 56:153–160CrossRefPubMed Alvarez-Martínez MJ, Miró JM, Valls ME, Moreno A, Rivas PV, Solé M, Domingo NP, Muñoz C, Rivera E (2006) Sensitivity and specificity of nested and real-time PCR for the detection of Pneumocystis jiroveci in clinical specimens. Diagn Microbiol Infect Dis 56:153–160CrossRefPubMed
go back to reference Azoulay E, Bergeron A, Chevret S, Bele N, Schlemmer B, Menotti J (2009) Polymerase chain reaction for diagnosing pneumocystis pneumonia in non-HIV immunocompromised patients with pulmonary infiltrates. Chest 135:655–661CrossRefPubMed Azoulay E, Bergeron A, Chevret S, Bele N, Schlemmer B, Menotti J (2009) Polymerase chain reaction for diagnosing pneumocystis pneumonia in non-HIV immunocompromised patients with pulmonary infiltrates. Chest 135:655–661CrossRefPubMed
go back to reference Bigby TD, Margolskee D, Curtis JL, Michael PF, Sheppard D, Hadley WK, Hopewell PC (1986) The usefulness of induced sputum in the diagnosis of Pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome. Am Rev Respir Dis 133:515–518PubMed Bigby TD, Margolskee D, Curtis JL, Michael PF, Sheppard D, Hadley WK, Hopewell PC (1986) The usefulness of induced sputum in the diagnosis of Pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome. Am Rev Respir Dis 133:515–518PubMed
go back to reference Broaddus C, Dake MD, Stulbarg MS, Blumenfeld W, Hadley WK, Golden JA, Hopewell PC (1985) Bronchoalveolar lavage and transbronchial biopsy for the diagnosis of pulmonary infections in the acquired immunodeficiency syndrome. Ann Intern Med 102:747–752CrossRefPubMed Broaddus C, Dake MD, Stulbarg MS, Blumenfeld W, Hadley WK, Golden JA, Hopewell PC (1985) Bronchoalveolar lavage and transbronchial biopsy for the diagnosis of pulmonary infections in the acquired immunodeficiency syndrome. Ann Intern Med 102:747–752CrossRefPubMed
go back to reference Cano MM, De La Horra C, Martin-Juan J, Varela J, Torronteras R, Respaldiza N, Medrano F, Calderón E (2004) Pneumocystis jiroveci genotypes in the Spanish population. Clin Infect Dis 39:123–128CrossRef Cano MM, De La Horra C, Martin-Juan J, Varela J, Torronteras R, Respaldiza N, Medrano F, Calderón E (2004) Pneumocystis jiroveci genotypes in the Spanish population. Clin Infect Dis 39:123–128CrossRef
go back to reference Gill V, Evans G, Stock F, Parrillo J, Masur H, Kovacs J (1987) Detection of Pneumocystis carinii by fluorescent-antibody stain using a combination of three monoclonal antibodies. J Clin Microbiol 25:1837–1840PubMedPubMedCentral Gill V, Evans G, Stock F, Parrillo J, Masur H, Kovacs J (1987) Detection of Pneumocystis carinii by fluorescent-antibody stain using a combination of three monoclonal antibodies. J Clin Microbiol 25:1837–1840PubMedPubMedCentral
go back to reference Gosey LL, Howard RM, Witebsky FG, Ognibene FP, Wu TC, Gill V, MacLowry JD (1985) Advantages of a modified toluidine blue O stain and bronchoalveolar lavage for the diagnosis of Pneumocystis carinii pneumonia. J Clin Microbiol 22:803–807PubMedPubMedCentral Gosey LL, Howard RM, Witebsky FG, Ognibene FP, Wu TC, Gill V, MacLowry JD (1985) Advantages of a modified toluidine blue O stain and bronchoalveolar lavage for the diagnosis of Pneumocystis carinii pneumonia. J Clin Microbiol 22:803–807PubMedPubMedCentral
go back to reference Grocott R (1955) A stain for fungi in tissue sections and smears using Gomori’s methenamine-silver nitrate technic. Am J Clin Pathol 25:975–979PubMed Grocott R (1955) A stain for fungi in tissue sections and smears using Gomori’s methenamine-silver nitrate technic. Am J Clin Pathol 25:975–979PubMed
go back to reference Helweg-Larsen J (2004) Pneumocystis jiroveci. Dissertation, University of Copenhagen Helweg-Larsen J (2004) Pneumocystis jiroveci. Dissertation, University of Copenhagen
go back to reference Hof H (2012) Pneumocystis jirovecii: a peculiar fungus posing particular problems for therapy and prophylaxis. Mycoses 55:1–7CrossRef Hof H (2012) Pneumocystis jirovecii: a peculiar fungus posing particular problems for therapy and prophylaxis. Mycoses 55:1–7CrossRef
go back to reference Jarboui M, Sellami A, Sellami H, Cheikhrouhou F, Makni F, Ben Arab N, Ben Jemaa M, Ayadi A (2010) Molecular diagnosis of Pneumocystis jiroveci pneumonia in immunocompromised patients. Mycoses 53:329–333PubMed Jarboui M, Sellami A, Sellami H, Cheikhrouhou F, Makni F, Ben Arab N, Ben Jemaa M, Ayadi A (2010) Molecular diagnosis of Pneumocystis jiroveci pneumonia in immunocompromised patients. Mycoses 53:329–333PubMed
go back to reference Kim T, Choi SH, Kim SH, Jeong JY, Woo JH, Kim YS, Sung H, Kim MN, Yoon DH, Suh C (2013) Point prevalence of Pneumocystis pneumonia in patients with non-Hodgkin lymphoma according to the number of cycles of R-CHOP chemotherapy. Ann Hematol 92:231–238CrossRefPubMed Kim T, Choi SH, Kim SH, Jeong JY, Woo JH, Kim YS, Sung H, Kim MN, Yoon DH, Suh C (2013) Point prevalence of Pneumocystis pneumonia in patients with non-Hodgkin lymphoma according to the number of cycles of R-CHOP chemotherapy. Ann Hematol 92:231–238CrossRefPubMed
go back to reference Kovacs J, Swan J, Shelhamer T, Gill V, Ognibene F, Parrillo J, Masur H (1986) Prospective evaluation of a monoclonal antibody in diagnosis of Pneumocystis carinii pneumonia. Lancet 328:1–3CrossRef Kovacs J, Swan J, Shelhamer T, Gill V, Ognibene F, Parrillo J, Masur H (1986) Prospective evaluation of a monoclonal antibody in diagnosis of Pneumocystis carinii pneumonia. Lancet 328:1–3CrossRef
go back to reference Kovacs JA, Ng VL, Leoung G, Hadley WK, Evans G, Lane HC, Ognibene FP, Shelhamer J, Parrillo JE (1988) Diagnosis of Pneumocystis carinii pneumonia: improved detection in sputum with use of monoclonal antibodies. N Eng J Med 318:589–593CrossRef Kovacs JA, Ng VL, Leoung G, Hadley WK, Evans G, Lane HC, Ognibene FP, Shelhamer J, Parrillo JE (1988) Diagnosis of Pneumocystis carinii pneumonia: improved detection in sputum with use of monoclonal antibodies. N Eng J Med 318:589–593CrossRef
go back to reference Marques S, Marcelino P, Baptista AM, Aldomiro F, Ribeiro J, Malhado J (2002) Pneumocystis carinii pneumonia in diabetic patient. Infect Dis Clin Pract 11:441–444CrossRef Marques S, Marcelino P, Baptista AM, Aldomiro F, Ribeiro J, Malhado J (2002) Pneumocystis carinii pneumonia in diabetic patient. Infect Dis Clin Pract 11:441–444CrossRef
go back to reference Masur H, Ognibene FP, Yarchoan R, Shelhamer JH, Baird BF, Travis W, Suffredini AF, Deyton L, Kovacs JA, Falloon J (1989) CD4 counts as predictors of opportunistic pneumonias in human immunodeficiency virus (HIV) infection. Ann Intern Med 111:223–231CrossRefPubMed Masur H, Ognibene FP, Yarchoan R, Shelhamer JH, Baird BF, Travis W, Suffredini AF, Deyton L, Kovacs JA, Falloon J (1989) CD4 counts as predictors of opportunistic pneumonias in human immunodeficiency virus (HIV) infection. Ann Intern Med 111:223–231CrossRefPubMed
go back to reference Ng V, Gartner I, Weymouth L, Goodman C, Hopewell P, Hadley W (1989) The use of mucolysed induced sputum for the identification of pulmonary pathogens associated with human immunodeficiency virus infection. Arch Pathol Lab Med 113:488–493PubMed Ng V, Gartner I, Weymouth L, Goodman C, Hopewell P, Hadley W (1989) The use of mucolysed induced sputum for the identification of pulmonary pathogens associated with human immunodeficiency virus infection. Arch Pathol Lab Med 113:488–493PubMed
go back to reference Ng V, Yajko D, McPhaul L, Gartner I, Byford B, Goodman C, Nassos P, Sanders C, Howes E, Leoung G (1990) Evaluation of an indirect fluorescent-antibody stain for detection of Pneumocystis carinii in respiratory specimens. J Clin Microbiol 28:975–979PubMedPubMedCentral Ng V, Yajko D, McPhaul L, Gartner I, Byford B, Goodman C, Nassos P, Sanders C, Howes E, Leoung G (1990) Evaluation of an indirect fluorescent-antibody stain for detection of Pneumocystis carinii in respiratory specimens. J Clin Microbiol 28:975–979PubMedPubMedCentral
go back to reference Post C, Fakouhi T, Dutz W, Bandarizadeh B, Kohout E (1971) Prophylaxis of epidemic infantile pneumocystosis with a 20: 1 sulfadoxine + pyrimethamine combination. Curr Ther Res Clin Exp 13:273–279PubMed Post C, Fakouhi T, Dutz W, Bandarizadeh B, Kohout E (1971) Prophylaxis of epidemic infantile pneumocystosis with a 20: 1 sulfadoxine + pyrimethamine combination. Curr Ther Res Clin Exp 13:273–279PubMed
go back to reference Rodiño J, Rincón N, Aguilar YA, Rueda ZV, Herrera M, Vélez LA (2011) Microscopic diagnosis of Pneumocystis jirovecii pneumonia in bronchoalveolar lavage and oropharyngeal wash samples of immunocompromised patients with pneumonia. Biomedica 31:222–231CrossRefPubMed Rodiño J, Rincón N, Aguilar YA, Rueda ZV, Herrera M, Vélez LA (2011) Microscopic diagnosis of Pneumocystis jirovecii pneumonia in bronchoalveolar lavage and oropharyngeal wash samples of immunocompromised patients with pneumonia. Biomedica 31:222–231CrossRefPubMed
go back to reference Sheikholeslami F, Sadraei MJ, Farnia P, Forozandeh M, Kochak HE (2013) Rate of Pneumocystis pneumonia in Iranian HIV + Patients with Pulmonary Infiltrates. Jundishapur J Microbiol 6:295–300 Sheikholeslami F, Sadraei MJ, Farnia P, Forozandeh M, Kochak HE (2013) Rate of Pneumocystis pneumonia in Iranian HIV + Patients with Pulmonary Infiltrates. Jundishapur J Microbiol 6:295–300
go back to reference Sing A, Trebesius K, Roggenkamp A, Rüssmann H, Tybus K, Pfaff F, Bogner JR, Emminger C, Heesemann J (2000) Evaluation of diagnostic value and epidemiological implications of PCR for Pneumocystis carinii in different immunosuppressed and immunocompetent patient groups. J Clin Microbiol 38:1461–1467PubMedPubMedCentral Sing A, Trebesius K, Roggenkamp A, Rüssmann H, Tybus K, Pfaff F, Bogner JR, Emminger C, Heesemann J (2000) Evaluation of diagnostic value and epidemiological implications of PCR for Pneumocystis carinii in different immunosuppressed and immunocompetent patient groups. J Clin Microbiol 38:1461–1467PubMedPubMedCentral
go back to reference Struijk GH, Gijsen AF, La Yong S, Zwinderman AH, Geerlings SE, Lettinga KD, Ten Berge IJ, Bemelman FJ (2011) Risk of Pneumocystis jiroveci pneumonia in patients long after renal transplantation. Nephrol Dial Transplant 26:3391–3398CrossRefPubMed Struijk GH, Gijsen AF, La Yong S, Zwinderman AH, Geerlings SE, Lettinga KD, Ten Berge IJ, Bemelman FJ (2011) Risk of Pneumocystis jiroveci pneumonia in patients long after renal transplantation. Nephrol Dial Transplant 26:3391–3398CrossRefPubMed
go back to reference Uemura N, Makimura K, Onozaki M, Otsuka Y, Shibuya Y, Yazaki H, Kikuchi Y, Abe S, Kudoh S (2008) Development of a loop-mediated isothermal amplification method for diagnosing Pneumocystis pneumonia. J Med Microbiol 57:50–57CrossRefPubMed Uemura N, Makimura K, Onozaki M, Otsuka Y, Shibuya Y, Yazaki H, Kikuchi Y, Abe S, Kudoh S (2008) Development of a loop-mediated isothermal amplification method for diagnosing Pneumocystis pneumonia. J Med Microbiol 57:50–57CrossRefPubMed
go back to reference Vahid B, Bibbo M, Marik PE (2007) Role of CD8 lymphocytes and neutrophilic alveolitis in Pneumocystis jiroveci pneumonia. Scand J Infect Dis Suppl 39:612–614CrossRef Vahid B, Bibbo M, Marik PE (2007) Role of CD8 lymphocytes and neutrophilic alveolitis in Pneumocystis jiroveci pneumonia. Scand J Infect Dis Suppl 39:612–614CrossRef
Metadata
Title
Prevalence of Pneumocystis jirovecii among immunocompromised patients in hospitals of Tehran city, Iran
Authors
Mohammad Mohsen Homayouni
Hamed Behniafar
Amir Sayed Ali Mehbod
Mohammad-Javad Mohammad-Sadeghi
Bahman Maleki
Publication date
01-09-2017
Publisher
Springer India
Published in
Journal of Parasitic Diseases / Issue 3/2017
Print ISSN: 0971-7196
Electronic ISSN: 0975-0703
DOI
https://doi.org/10.1007/s12639-017-0901-y

Other articles of this Issue 3/2017

Journal of Parasitic Diseases 3/2017 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.